Carnegie Investment Counsel trimmed its holdings in shares of Relx Plc (NYSE:RELX – Free Report) by 92.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,724 shares of the technology company’s stock after selling 346,620 shares during the quarter. Carnegie Investment Counsel’s holdings in Relx were worth $952,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in Relx during the fourth quarter valued at approximately $26,000. Cornerstone Planning Group LLC boosted its stake in Relx by 2,574.1% in the fourth quarter. Cornerstone Planning Group LLC now owns 722 shares of the technology company’s stock valued at $27,000 after acquiring an additional 695 shares in the last quarter. Transamerica Financial Advisors LLC grew its holdings in Relx by 3,040.0% in the fourth quarter. Transamerica Financial Advisors LLC now owns 785 shares of the technology company’s stock worth $32,000 after purchasing an additional 760 shares during the last quarter. Whipplewood Advisors LLC grew its holdings in Relx by 2,468.4% in the first quarter. Whipplewood Advisors LLC now owns 976 shares of the technology company’s stock worth $32,000 after purchasing an additional 938 shares during the last quarter. Finally, Manchester Capital Management LLC increased its position in shares of Relx by 1,823.6% during the fourth quarter. Manchester Capital Management LLC now owns 1,058 shares of the technology company’s stock worth $43,000 after purchasing an additional 1,003 shares in the last quarter. Institutional investors own 15.02% of the company’s stock.
Relx Trading Up 3.1%
NYSE RELX opened at $33.43 on Tuesday. The stock has a 50-day simple moving average of $32.87 and a two-hundred day simple moving average of $34.65. The company has a current ratio of 0.49, a quick ratio of 0.44 and a debt-to-equity ratio of 2.38. Relx Plc has a fifty-two week low of $27.57 and a fifty-two week high of $54.03.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on RELX
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Further Reading
- Five stocks we like better than Relx
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
